Darren R. Hodgson
Oncology R&D
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Associations between early changes in circulating tumor DNA (ctDNA) and outcomes across randomized trials: Insights from the ctMoniTR project.
Journal: The journal of liquid biopsy
Published: June 15, 2026
Beyond Circulating Tumor DNA for Efficacy: Can We Use Cell-Free DNA to Detect and Monitor Toxicity Signals?
Journal: JCO precision oncology
Published: May 21, 2026
Variability of Circulating Tumor DNA Levels in Plasma Samples From Patients With Advanced Non-Small-Cell Lung Cancer in the Absence of Treatment.
Journal: JCO precision oncology
Published: October 30, 2025
Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 23, 2025
Clinicopathological Predictors of the Presence of Blood Circulating Tumor DNA in Early-Stage Non-Small Cell Lung Cancers.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 25, 2024
Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 19, 2024
Reply to S. Sorscher.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 11, 2024
Low T cell diversity associates with poor outcome in bladder cancer: A comprehensive longitudinal analysis of the T cell receptor repertoire.
Journal: Cell reports. Medicine
Published: August 30, 2024
Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 16, 2024
Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 02, 2024
Prognostic implication of methylation-based circulating tumor DNA detection prior to surgery in stage I non-small cell lung cancer.
Journal: Cancer letters
Published: March 19, 2024
Last Updated: 09/26/2026